The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 16, 2014

Filed:

Apr. 05, 2013
Applicant:

Emory University, Atlanta, GA (US);

Inventor:

Mark M. Goodman, Atlanta, GA (US);

Assignee:

Emory University, Atlanta, GA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 51/00 (2006.01); A61M 36/14 (2006.01); C07B 59/00 (2006.01); C07D 345/00 (2006.01); C07D 291/04 (2006.01); A61K 51/04 (2006.01); C07C 229/48 (2006.01); C07F 13/00 (2006.01);
U.S. Cl.
CPC ...
C07C 229/48 (2013.01); C07B 59/001 (2013.01); C07D 345/00 (2013.01); C07D 291/04 (2013.01); C07C 2101/04 (2013.01); A61K 51/0406 (2013.01); C07F 13/005 (2013.01); A61K 51/0402 (2013.01);
Abstract

The present invention provides novel amino acid compounds useful in detecting and evaluating brain and body tumors. These compounds have the advantageous properties of rapid uptake and prolonged retention in tumors and can be labeled with halogen isotopes such as fluorine-18, iodine-123, iodine-124, iodine-125, iodine-131, bromine-75, bromine-76, bromine-77, bromine-82, astatine-210, astatine-211, and other astatine isotopes. These compounds can also be labeled with technetium and rhenium isotopes using known chelation complexes. The compounds disclosed herein bind tumor tissues in vivo with high specificity and selectivity when administered to a subject. Preferred compounds show a target to non-target ratio of at least 2:1, are stable in vivo and substantially localized to target within 1 hour after administration. Preferred compounds include 1-amino-2-[F]fluorocyclobutyl-1-carboxylic acid (2-[F]FACBC) and 1-amino-2-[]fluoromethylcyclobutyl-1-carboxylic acid (2-[F]FMACBC). The labeled amino acid compounds of the invention are useful as imaging agents in detecting and/or monitoring tumors in a subject by PET or SPECT.


Find Patent Forward Citations

Loading…